Recent Advances and Novel Approaches in Laboratory-Based Diagnostic Mycology
What was once just culture and microscopy the field of diagnostic mycology has significantly advanced in recent years and continues to incorporate novel assays and strategies to meet the changes in clinical demand. The emergence of widespread resistance to antifungal therapy has led to the developme...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/7/1/41 |
id |
doaj-3d60663ea4544a52bddcbd517f0f77ee |
---|---|
record_format |
Article |
spelling |
doaj-3d60663ea4544a52bddcbd517f0f77ee2021-01-12T00:02:50ZengMDPI AGJournal of Fungi2309-608X2021-01-017414110.3390/jof7010041Recent Advances and Novel Approaches in Laboratory-Based Diagnostic MycologyLewis P. White0Jessica S. Price1Mycology Reference Laboratory, Public Health Wales, Microbiology Cardiff, Cardiff CF14 4XW, UKMycology Reference Laboratory, Public Health Wales, Microbiology Cardiff, Cardiff CF14 4XW, UKWhat was once just culture and microscopy the field of diagnostic mycology has significantly advanced in recent years and continues to incorporate novel assays and strategies to meet the changes in clinical demand. The emergence of widespread resistance to antifungal therapy has led to the development of a range of molecular tests that target mutations associated with phenotypic resistance, to complement classical susceptibility testing and initial applications of next-generation sequencing are being described. Lateral flow assays provide rapid results, with simplicity allowing the test to be performed outside specialist centres, potentially as point-of-care tests. Mycology has responded positively to an ever-diversifying patient population by rapidly identifying risk and developing diagnostic strategies to improve patient management. Nowadays, the diagnostic repertoire of the mycology laboratory employs classical, molecular and serological tests and should be keen to embrace diagnostic advancements that can improve diagnosis in this notoriously difficult field.https://www.mdpi.com/2309-608X/7/1/41mycologynovel targets and applicationsnext-generation sequencingadvances in serologyadvances in molecular diagnostics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lewis P. White Jessica S. Price |
spellingShingle |
Lewis P. White Jessica S. Price Recent Advances and Novel Approaches in Laboratory-Based Diagnostic Mycology Journal of Fungi mycology novel targets and applications next-generation sequencing advances in serology advances in molecular diagnostics |
author_facet |
Lewis P. White Jessica S. Price |
author_sort |
Lewis P. White |
title |
Recent Advances and Novel Approaches in Laboratory-Based Diagnostic Mycology |
title_short |
Recent Advances and Novel Approaches in Laboratory-Based Diagnostic Mycology |
title_full |
Recent Advances and Novel Approaches in Laboratory-Based Diagnostic Mycology |
title_fullStr |
Recent Advances and Novel Approaches in Laboratory-Based Diagnostic Mycology |
title_full_unstemmed |
Recent Advances and Novel Approaches in Laboratory-Based Diagnostic Mycology |
title_sort |
recent advances and novel approaches in laboratory-based diagnostic mycology |
publisher |
MDPI AG |
series |
Journal of Fungi |
issn |
2309-608X |
publishDate |
2021-01-01 |
description |
What was once just culture and microscopy the field of diagnostic mycology has significantly advanced in recent years and continues to incorporate novel assays and strategies to meet the changes in clinical demand. The emergence of widespread resistance to antifungal therapy has led to the development of a range of molecular tests that target mutations associated with phenotypic resistance, to complement classical susceptibility testing and initial applications of next-generation sequencing are being described. Lateral flow assays provide rapid results, with simplicity allowing the test to be performed outside specialist centres, potentially as point-of-care tests. Mycology has responded positively to an ever-diversifying patient population by rapidly identifying risk and developing diagnostic strategies to improve patient management. Nowadays, the diagnostic repertoire of the mycology laboratory employs classical, molecular and serological tests and should be keen to embrace diagnostic advancements that can improve diagnosis in this notoriously difficult field. |
topic |
mycology novel targets and applications next-generation sequencing advances in serology advances in molecular diagnostics |
url |
https://www.mdpi.com/2309-608X/7/1/41 |
work_keys_str_mv |
AT lewispwhite recentadvancesandnovelapproachesinlaboratorybaseddiagnosticmycology AT jessicasprice recentadvancesandnovelapproachesinlaboratorybaseddiagnosticmycology |
_version_ |
1724340984401100800 |